[Link]
http://crossmark.crossref.org/dialog/?doi=10.1016/j.neuro.2016.02.010&domain=pdf
[Link]
mailto:giuliawp@gmail.com
[Link]
mailto:lorena.furieri@ufes.br
[Link]
mailto:ana.briones@uam.es
[Link]
mailto:marisol.avendanno@uam.es
[Link]
mailto:daltonv2@terra.com.br
[Link]
mailto:mercedes.salaices@uam.es
[Link]
mailto:mariajesus.alonso@urjc.es
[Link]
http://dx.doi.org/10.1016/j.neuro.2016.02.010
[Link]
http://dx.doi.org/10.1016/j.neuro.2016.02.010
[Link]
http://www.sciencedirect.com/science/journal/0161813X
Full length article
Cerebrovascularendothelialdysfunctioninducedbymercuryexposure
at low concentrations
Giulia Alessandra Wiggersa,c,Lorena Barros Furierib,c,Ana María Brionesc,
María Soledad Avendañoc, Franck Maciel Peçanhaa,c, Dalton Valentim Vassallob,
Mercedes Salaicesc,María Jesús Alonsod,*
aPostgraduate Program in Biochemistry, Universidade Federal do Pampa, Rio Grande do Sul, Unipampa, Campus Uruguaiana, BR 472, km 592, PO Box 118,
Uruguaiana, RS 97500-970, Brazil
bDepartment of Physiological Sciences, Universidade Federal do Espírito Santo, Vitória, Espírito Santo, Avenida Marechal Campos, 1468, Vitória, ES 29040-090,
Brazil
cDepartment of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Calle Arzobispo Morcillo s/n, 28029 Madrid, Spain
dDepartment of Ciencias Básicas de la Salud, Universidad Rey Juan Carlos, Avenida de Atenas s/n, 28922 Alcorcón, Madrid, Spain
A R T I C L E I N F O
Article history:
Received 7 September 2015
Received in revised form 24 February 2016
Accepted 25 February 2016
Available online 2 March 2016
Keywords:
Mercury
Cerebral arteries
Reactive oxygen species
Vascular reactivity and prostanoids
A B S T R A C T
Mercury (Hg) has many harmful vascular effects by increasing oxidative stress, inflammation and
vascular/endothelialdysfunction,allofwhichmaycontributetocerebrovasculardiseasesdevelopment.
We aimed to explore the effects of chronic low-mercuryconcentration on vascular function in cerebral
arteries and the mechanisms involved. Basilar arteries from control (vehicle—saline solution, im) and
mercurychloride(HgCl
2
)-treatedratsfor30days(firstdose4.6mg/kg,subsequentdose0.07mg/kg/day,
im, to cover daily loss) were used. Vascular reactivity, protein expression, nitric oxide (NO) levels and
superoxideanion(O
2
)productionwereanalyzed.HgCl
2
exposureincreasedserotonincontractionand
reduced the endothelium-dependent vasodilatation to bradykinin. After NO synthase inhibition,
serotonin responses were enhanced more in control than in mercury-treated rats while bradykinininduced relaxation was abolished. NO levels were greater in control than Hg-treated rats. Tiron and
indomethacinreducedvasoconstrictionandincreasedthebradykinin-inducedrelaxationonlyinHgCl
2
-
treated rats. Vascular O
2
 production was greater in mercury-treated when compared to control rats.
ProteinexpressionsofendothelialNOsynthase,copper/zinc(Cu/Zn),Manganese(Mn)andextracellularsuperoxide dismutases were similar in cerebral arteries from both groups. Results suggest that Hg
treatment increases cerebrovascular reactivity by reducing endothelial negative modulation and NO
bioavailability; this effect seems to be dependenton increasedreactive oxygenspecies and prostanoids
generation. These findings show, for the first time, that brain vasculature are also affected by chronic
mercury exposure and offer further evidence that even at small concentration, HgCl
2
is hazardous and
might be an environmental risk factor accounting for cerebral vasospasm development.
ã 2016 Elsevier Inc. All rights reserved.
1. Introduction
Cerebral vasospasm causes reduction in nervous tissue perfusion that may lead to ischemia and brain injury (Ducruet et al.,
2010;IzzyandMuehlschlegel,2014).Althoughreversible,depending on time and severity, the vasospasm can attain an infarction
condition. Among the different mechanisms that induce cerebral
vasospasm highlights the increase of free radicals production and
the reduction in nitric oxide (NO) bioavailability (Carret al., 2013;
Izzy and Muehlschlegel, 2014).
Several reports have described a close link between mercury
and cardiovascular diseases such as carotid atherosclerosis,
myocardial infarction, coronary heart disease and hypertension
(Salonen et al., 2000; Virtanen et al., 2005; Houston, 2011). The
deleteriouseffectsofmercuryinseveralsystemsareassociatedto
increasedoxidativestress(WolfandBaynes,2007;Houston,2011;
Farina et al., 2013). In addition, exposure to low mercury
concentrations leads to reactive oxygen species (ROS) production
in both conductance and resistance arteries (Wiggers et al., 2008;
* Corresponding author at: Avda. de Atenas s/n, 28922 Alcorcon, Madrid, Spain.
Fax: +34 91 4888831.
E-mail addresses: giuliawp@gmail.com (G.A. Wiggers), lorena.furieri@ufes.br
(L.B. Furieri), ana.briones@uam.es (A.M. Briones), marisol.avendanno@uam.es
(M.S.Avendaño),daltonv2@terra.com.br(D.V.Vassallo),mercedes.salaices@uam.es
(M. Salaices), mariajesus.alonso@urjc.es (M.J. Alonso).
http://dx.doi.org/10.1016/j.neuro.2016.02.010
0161-813X/ã 2016 Elsevier Inc. All rights reserved.
NeuroToxicology 53 (2016) 282–289
Contents lists available at ScienceDirect
NeuroToxicology
(TRIAL PDF Extractor SDK 8.0.0.2542-774980772)
Furieri et al., 2011; Lemos et al., 2012; Rizzetti et al., 2013).
Regarding other mercury effects derived from chronic exposure,
previous results showed that at nanomolar concentrations
mercury chloride (HgCl
2
) increases the vascular reactivity to
phenylephrine. The increased reactivity might provide a baseline
condition for favoring vasospasm development. This enhancing
effect is mediated by endothelium and involves the NO bioavailability reduction likely as a consequence of the increased ROS
production (Wiggers et al., 2008; Furieri et al., 2011). In addition,
mercury exposure also increases the release of vasoconstrictor
prostanoids and its participation in phenylephrine responses
(Pecanha et al., 2010), thus contributing to the increased
vasoconstrictor response.
Endothelium has been described to be affected by concentrations of heavy metals below the reference values (Kim et al.,
2014; Choi et al., 2015; Tinkov et al., 2015), which highlights the
importanceofabetterunderstandingofthemechanismsbywhich
these metals promotecardiovascular impairment. However, there
are no reports analyzing whether exposure to low concentrations
of mercury affects vascular reactivity of cerebral arteries. The
currentstudyaimedtoexploretheeffectsofachronicexposureto
low concentration of mercury in endothelial function of isolated
basilar arteries as well as the possible involvement of oxidative
stress and prostanoids generation in these effects.
2. Material and methods
2.1. Animals
All animal care and experimental procedures complied with
current guidelines for biomedical research stated by the Brazilian
SocietiesofExperimentalBiologyandwereapprovedbytheEthics
Committee on Animal Experimentation of Federal University of
Pampa—CEUA/Unipampa, Uruguaiana, Brazil (process number:
020/2012).
Three month-old male normotensive Wistar rats (280–300g,
n=38) were obtained from colonies maintained at the Animal
QuartersoftheFederalUniversityofPampa.Duringtreatment,rats
were housed at a constant room temperature, humidity and light
cycle (12:12h light–dark). Rats had free access to tap water and
were fed with standard chow ad libitum. Rats were divided into
two groups: control (vehicle—saline solution, im) and rats treated
with HgCl
2
for 30 days (first dose 4.6mg/kg, subsequent dose
0.07mg/kg/day,imtocoverdailyloss).Aspreviouslyreported,this
treatment leads to blood mercury concentrations of 80.6ng/
mL (Wiggers et al., 2008).
2.2. Vascular reactivity measurements of basilar artery
After30daysoftreatmentwitheitherHgCl
2
orvehicle,ratswere
killed by decapitation. Basilar artery was isolated and segments of
2mm in length were mounted in a small vessel dual chamber
myograph for measurement of isometric tension, according to
previously described by Hernanz et al. (2008). After 30min of
equilibrationperiod in oxygenated Krebs–Henseleit solution (KHS,
contained(mmol/L):115 NaCl,25NaHCO
3
,4.7KCl,1.2 MgSO
4
7H
2
O,
2.5CaCl
2
,1.2KH
2
PO
4
,11.1glucoseand0.01Na
2
EDTA)at37 CandpH
7.4, segments were stretched to their optimal lumen diameter for
active tension development. Basilararterysegments were exposed
to a high K+ solution (120mmol/LK+-KHS, which was identical to
KHSexceptthatNaClwasreplacedbyKCl onanequimolarbasis)in
ordertochecktheirfunctionalintegrity.Mercurytreatmentdidnot
affect K+-KHS response (Control: 2.050.19 vs HgCl
2
: 2.290.18
mNmm1,P>0.05).
Concentration–response curves to bradykinin (BK, 1nmol/L–
10mmol/L) or to diethylamine NONOate (DEA-NO, 1nmol/L–
10mmol/L)werethenperformedinarteries previouslycontracted
with serotonin (5-HT) at a concentration that produced approximately 50% of the contraction induced by K+-KHS in each case.
After a washout period of 60min, concentration-response curves
to 5-HT (3nmol/L–0.1mmol/L) were constructed. A single
concentration–dependent curve to BK and 5-HT was performed
ineachsegment.Aparallelstudywasperformedtoinvestigatethe
effects of the NO synthase (NOS) inhibitor N-nitro-L-arginine
methylester(L-NAME,100mmol/L),theROS scavengersuperoxide
dismutase (SOD, 150U/mL), the cyclooxygenase (COX) inhibitor
indomethacin (10mmol/L), the superoxide anion scavenger Tiron
(1mmol/L) and the presumed NADPH oxidase inhibitor apocynin
(300mmol/L) by its addition 30min prior to BK or 5-HT.
2.3. Nitric oxide release
NO release was measured as previously described (Hernanz
et al., 2008). For this, basilar arteries were dissected and
equilibrated for 60min in HEPES buffer (inmmol/L: 119 NaCl; 20
HEPES; 1.2 CaCl
2
; 4.6 KCl; 1 MgSO
4
; 0.4 KH
2
PO
4
; 5 NaHCO
3
;
5.5 glucose; 0.15 NaH
2
PO
4
; pH 7.4) at 37 C; arteries were then
incubatedwiththefluorescentprobe4,5-diaminofluorescein(DAF,
2mmol/L) for 1h and the mediumwas collected to measure basal
NOrelease.5-HT(1mmol/L)andBK(10mmol/L)wereappliedand
the medium collected to measure stimulated NO production. The
fluorescence of the medium was measured at room temperature
using a spectrofluorometer (LS50 PerkinElmer instruments, FL
WINLAB Software, Buckinghamshire, UK) with excitation wavelength set at 492nm and emission wavelength at 515nm. Blank
measurementsamplesweresimilarlycollectedwithoutarteriesto
subtract background emission. The amount of NO released was
expressed as arbitrary units/mg tissue. Samples from untreated
rats were used as controls and variations were calculated relative
to control values.
2.4. ROS production
Superoxide anion (O
2
) levels were measured in cerebral
arteries using lucigenin chemiluminescence, as previously described (Furieri et al., 2011). Briefly, arteries were equilibrated for
30mininHEPESbufferat37 C,transferredtotesttubescontaining
1mL HEPES buffer (pH 7.4) with lucigenin (250mmol/L) and then
keptat37 C.Theluminometerwas settoreportarbitraryunitsof
emitted light; repeated measurements were collected during
5minat10sintervalsandaveraged.Tiron(1mmol/L)wasaddedto
quench the O
2
-dependent chemiluminescence. Blank samples
weresimilarlycollectedfrommediumwithoutarteriesinorderto
subtract background emission. The data were expressed as
units/mg tissue per min.
2.5. Western blot analysis
Proteins from homogenized cerebral arteries (20mg for
Cu/Zn-SOD and eNOS, 5mg for Mn-SOD and 10mg for extracellular (EC)-SOD) were electrophoretically separated by 7.5% (eNOS)
or 12% (Cu/Zn-, Mn-, and EC-SOD) SDS-PAGE. Proteins were
transferred to polyvinyl difluoride membranes that were incubated with eithermouse monoclonalantibody foreNOS (1:1000;
Transduction Laboratories, Lexington, UK) or rabbit polyclonal
antibodies for Cu/Zn-SOD (1:1000; StressGen, Victoria, Canada),
Mn-SOD (1:20,000; StressGen) or EC-SOD (1:1000; StressGen).
Afterbeingwashed,membraneswereincubatedwithanti-mouse
(1:5000;StressGen)oranti-rabbit(1:2000;Bio-RadLaboratories,
Hercules, CA, USA) immunoglobulin conjugated to horseradish
peroxidase. Thereafter, immunocomplexes were detected using
an enhanced hoseradish peroxidase/luminol chemiluminescence
G.A. Wiggers et al./NeuroToxicology 53 (2016) 282–289 283
(PDF Extractor SDK TRIAL VERSION)
system (ECL Plus; Amersham International, Little Chalfont, UK)
and subjected to autoradiography (Hyperfilm ECL International).
Signals on the immunoblot were quantified with a National
Institutes of Health Image V1.56 computer program. Homogenates from human endothelial cells and rat brain were used as a
positivecontrolforeNOSandtheSOD isoforms,respectively. The
samemembranewasusedtodeterminea-actinexpressionusing
a mouse monoclonal antibody (1:300,000; Sigma Chemical, St.
Louis, MO, USA). Data are expressed as the ratio between signals
on the immunoblot corresponding to the studied protein and
a-actin.
2.6. Data analysis and statistics
Vasoconstrictor responses induced by 5-HT were expressed as
percentages of the tension generated by 120mmol/LK+-KHS.
Vasodilatorresponsesareexpressedaspercentageoftheprevious
contraction.Tocomparetheeffectofdrugsontheresponseto5-HT
in cerebral arteries from both groups of rats, some results were
expressedasdifferencesofareaundertheconcentration-response
curves (dAUC) in control and experimental situations. AUCs were
calculatedfromindividualconcentration-responsecurveplots;the
differences were expressed as percentage of AUC of the control
situation.
All values are expressed as meanSEM of the number of
animals used in each experiment. Results were analyzed using
either Student’s t-test, completely randomized two-way ANOVA
for comparison between groups or repeated-measure two-way
ANOVA for comparing treatments within the same group. When
ANOVA showed a significant treatment effect, Bonferroni’s post
hoc test was used to compare individual means. Differences were
considered statistically significant at P values<0.05.
2.7. Drugs and reagents
L-NAME, BK, apocynin, 5-HT, EDTA, HEPES, DAF, DEA-NO,
lucigenin,SOD,TironandindomethacinwereobtainedfromSigma
Chemical Co. All drugs were dissolved in distilled water except
lucigenin, which was dissolved in Krebs-HEPES, indomethacin,
whichwasdissolvedin1.5mmol/LNaHCO
3
andapocynininDMSO.
3. Results
The body weight gain, daily food intake, volume water
consumed, urine volume and blood pressure during 30days of
treatment were similar in both groups (results not shown), as
previously described (Wiggers et al., 2008).
3.1.Treatmentwithmercurychlorideinducedendothelialdysfunction
and reduced NO bioavailability in basilar arteries
Fig. 1 shows that 30 days of mercury treatment increased
vasoconstrictor responses to 5-HT and impaired endothelium
dependent vasodilatation toBK. However, no differences between
the two groups were observed in the endothelium-independent
relaxationproducedbyDEA-NO,suggestingthatNOsignalingwas
not affected.
The NOS inhibitor L-NAME (100mmol/L) enhanced 5-HT-
induced contraction in basilar arteries from both groups
(Fig. 2A), this effect being greater in arteries from control than
HgCl
2
treated rats (Fig. 2a). On the other hand, L-NAME almost
abolished BK-induced relaxation in both groups, suggesting the
dependence on NO of such relaxation (Fig. 2B). Both basal and
stimulated NO release was lower in basilar arteries from mercury
treated rats when compared with control (Fig. 2C). However,
vascular eNOS expression remained unmodified by mercury
treatment (Fig. 2D). All these results suggest a decreased NO
bioavailability after mercury treatment.
3.2. Treatment with mercury chloride increased oxidative stress in
basilar arteries
Previous results indicate that endothelial dysfunction induced
byHgCl
2
indifferentvascularbedsseemstobecausedbyincreased
ROS production (Wolf and Baynes, 2007; Wiggers et al., 2008;
Pecanhaetal.,2010;Furierietal.,2011;Lemosetal.,2012).Fig.3A
shows that the antioxidant Tiron (1mmol/L) did not modify 5-HT
responses in basilar arteries from the control group but reduced
the increased reactivity to 5-HT produced by mercury treatment.
Similarly,theNADPHoxidaseinhibitorapocynin(300mmol/L)did
not change the reactivity of basilar arteries to 5-HT in control
animals but reduced that responses in arteries from mercury
treated rats (results not shown). On the other hand, both Tiron
(Fig. 3B) and SOD (150U/mL, results not shown) improved the
impaired vasodilator response observed in segments from
mercury-treated rats.In addition,vascular production of superoxide anionwas greaterin cerebral arteriesfromHgCl
2
-treated than
control rats (Fig. 3C).
Fig.1. Treatment with mercurychlorideincreasesvasoconstrictor responsesand reducesendotheliumdependent vasodilatorresponsesin basilararteries.Concentration–
response curves to serotonin (5-HT, A), bradykinin (BK, B) and diethylamine NONOate (DEA-NO, C) in arteries from control and HgCl2-treated rats. Data represent
meanSEM. *P<0.05, by 2-way randomized ANOVA and Bonferroni post-test. Number of animals in parentheses.
284 G.A. Wiggers et al./NeuroToxicology 53 (2016) 282–289
(8.0.0.2542.1531326834 PDF Extractor SDK TRIAL VERSIOn)
These results suggest that mercury exposure increased the
superoxide anion production which would contribute for the
decreased NO bioavailability.
The increased oxidative stress induced by mercury might be
alsoduetothereductioninantioxidantdefences.However,protein
expression of the three SOD isoforms was not altered by the
treatment(Fig.4),discardingthatprooxidanteffectofHgwas due
to impairment of antioxidant defences.
3.3.Treatmentwithmercurychlorideaffectedprostanoidsproduction
in basilar arteries
Increasedvasoconstrictorprostanoidsproductionhasalsobeen
implicated in the reduction of NO bioavailability and the
subsequent endothelial dysfunction observed in some cardiovascular diseases (Feletou et al., 2010; Hernanz et al., 2014).
To investigate this issue, we used indomethacin, a non-selective
COXinhibitor.Theincubationofbasilararterieswithindomethacin
(10mmol/L) reduced the vasoconstrictor responses to 5-HT
(Fig. 5A) and increased the vasodilator responses to BK (Fig. 5B),
but only in the mercury-treated group.
3.4. Discussion
Results presented herein show, for thefirst time, that function
of cerebral arteries is affectedbychronic mercuryexposure. Thus,
aftermercuryexposurethevascularreactivityofbasilararteriesto
5-HT is increased whereas endothelium dependent vasodilator
response to BK is reduced. Increased ROS levels and COX-derived
products seem to contribute to NO bioavailability reduction as a
possible mechanism involved in this toxic effect of mercury at
cerebrovascular level.
Fig.2. TreatmentwithmercurychloridereducesNObioavailabilityinbasilararteries.(AandB)Effectof L-NAME(100mmol/L)onthevasoconstrictorresponsesto5-HTand
onthe vasodilatorresponsestobradykinin(BK)in basilararteriesfromcontroland HgCl
2
-treated rats.*P<0.05, by2-wayrandomizedANOVA and Bonferronipost-test.(a
andb)Differencesinareaundertheconcentration–responsecurve(dAUC)to5-HTandBKinthepresenceandtheabsenceof L-NAME.*P<0.05,byStudent sttest.(C)Basal
and stimulatedproductionofNO inarteriesfromcontroland HgCl2-treated rats.*P<0.05, byone-wayANOVA. (D)Representativeblotand densitometricanalysisofeNOS
protein expression normalized witha-actin expression in arteries from control and HgCl
2
treated rats. Data represent meanSEM. Number of animals in parentheses.
G.A. Wiggers et al./NeuroToxicology 53 (2016) 282–289 285
(DEMO PDF Extractor SDK 8.0.0.2542-1830995263)
Toxicological consequences induced by mercury in diverse
systems are already reported since the metal accumulates in
severalorganswhereitstoxicityiswelldescribed(Carmignaniand
Boscolo, 1984; Carmignani et al., 1992; Perottoni et al., 2004;
Fig.3. Treatmentwithmercurychlorideincreasedsuperoxideanionproductionanditscontributiontovascularresponsesinbasilararteries.EffectofTiron(1mmol/L)onthe
vasoconstrictorresponsesto5-HT(A)andBK(B)inarteriesfromcontrolandHgCl2. P<0.05,by2-wayrandomizedANOVAandBonferronipost-test.(b)Differencesinarea
undertheconcentration–responsecurve(dAUC)toBKinthepresenceandtheabsenceofTiron.(C)Effectoftreatmentwithmercurychlorideonsuperoxideanionproduction
measuredbylucigeninchemiluminescence,inarteriesfrombothcontrolandHgCl
2
-treatedrats.*P<0.05,Studentt-test.DatarepresentmeanSEM.Numberofanimalsin
parentheses.
Fig.4. TreatmentwithmercurychloridedidnotaffectSODexpressionsinbasilararteries.RepresentativeblotanddensitometricanalysisshowingCu/Zn-SOD,Mn-SODand
EC-SOD protein expressions normalized with a-actin expression in arteries from control and HgCl2 treated rats. Data represent meanSEM. Number of animals in
parentheses.
286 G.A. Wiggers et al./NeuroToxicology 53 (2016) 282–289
(EVALUATION PDF Extractor SDK 8.0.0.2542.873195581)
Francoetal.,2007;Wiggersetal.,2008;BridgesandZalups,2010).
Humanexposureeffectsdependonitschemicalformoccurringby
inhalation, ingestion and consumption via food chain, mainly by
intake from fish, among other sources (Salonen et al., 1995;
Langworth et al., 1997; Bjorkman et al., 1997; Zhang et al., 2011;
Nyland et al., 2012). The reference blood concentration recommendedbytheUSEnviromentalProtectionAgency’sofmercuryis
of 5.8ng/mL, and below this level, exposure is considered to be
withoutadverseeffects(NAS,2000;Rice,2004;Stern,2005).Blood
mercury concentration in the control population is around
1ng/mL; however, in workers occupationally exposed to mercury
or in residents of Guizhou (China), an area where mercury
contamination is well known, blood levels are around 60.8ng/mL
(Chen et al., 2005). A biomonitoring study made in citizens from
New York indicated that the blood mercury concentration was
around 2.73ng/mL while in regular fish consumers it reached
5.65ng/mL(McKelveyetal.,2007).Additionally,arecentstudyhas
described that mercury levels in occupational dental workers are
of 16.4ng/mL (Shirkhanloo et al., 2014). In the present study, we
used a protocol of exposure to mercury chloride that attains a
blood mercury content of around 8ng/mL (Wiggers et al., 2008),
close to the values of exposed humans.
Cerebral arteries are terminal vascular beds that when
presenting reduced blood flow might produce deleterious effects
on the neural tissue. Cerebral artery vasospasm is one important
feature of the causes for such outcome. Among risk factors that
havehighmorbidityandmortality,cerebralvasospasmrepresents
an important issue. The underlying mechanism for the
pathogenesis of vasospasm is multifactorial (Carr et al., 2013;
IzzyandMuehlschlegel,2014).Mercuryisahighriskenvironmental pollutant for public health which can cross the blood-brain
barrier(Zhangetal.,2011);therefore,itisplausiblethatthismetal
can affect brain function. In fact, in a previous report we have
shown that chronic exposure to low mercury chloride concentrations impairs memory formation (Mello-Carpes et al., 2013).
However,therearenopreviousreportsshowingtheassociationof
mercury exposure with changes in vascular reactivity of cerebral
vessels. In the present study we found that in vivo exposure to
mercury decreased the endothelium-dependent vasodilator
responses to BK whereas enhanced the vasoconstriction to 5-HT
ofbasilararteries.DecreasedNObioavailabilitycanaccountforthe
endothelial dysfunction induced by mercury exposure in basilar
arteries, as previouslyobservedin aorta, mesentericand coronary
arteries (Wiggers et al., 2008; Furieri et al., 2011). Accordingly, a
reduced NO modulation of vasoconstrictor responses was
observed in arteries from mercury-treated rats, as suggested by
the reduced effects of L-NAME. In agreement, NO levels were also
reduced, although eNOS expression did not change, suggesting
thatthedecreaseonNOlevelsmightbeexplainedbyanincreased
metabolism.
Previousreportshaveshownthatmercurytoxicityisassociated
withincreasedoxidativestress.Indeed,ROSaccumulationinduced
by high concentrations of HgCl
2
results in cytotoxicity of
endothelial cell monolayers (Wolf and Baynes, 2007). Mercury
exposure in animals or humans induces the ROS generation and
consequently produces oxidative damage in several organs and
Fig. 5. Treatment with mercury chloride increases the participation of COX-derived prostanoids on vasoconstrictor and endothelium dependent vasodilator responses of
basilararteries.(AandB)Effectofindomethacin(Indo,10mmol/L)onthevasoconstrictorresponsesto5-HTandthevasodilatorresponsestobradykinin(BK)inarteriesfrom
Control and HgCl
2
-treated rats. Data represent meanSEM. *P<0.05, by 2-way randomized ANOVA and Bonferroni post-test. Number of animals in parentheses.
G.A. Wiggers et al./NeuroToxicology 53 (2016) 282–289 287
(TRIAL PDF Extractor SDK 8.0.0.2542-2055788613)
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0005
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0005
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0005
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0005
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0005
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0010
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0010
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0015
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0015
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0020
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0020
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0025
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0025
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0025
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0030
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0030
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0035
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0035
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0035
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0040
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0040
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0040
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0040
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0045
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0045
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0045
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0045
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0050
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0050
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0050
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0050
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0055
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0055
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0055
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0060
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0060
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0065
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0065
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0070
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0070
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0070
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0070
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0075
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0075
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0075
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0075
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0075
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0080
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0080
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0080
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0080
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0085
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0085
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0085
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0085
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0090
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0090
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0090
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0095
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0095
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0100
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0100
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0105
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0105
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0110
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0110
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0110
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0110
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0115
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0115
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0115
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0120
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0120
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0120
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0120
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0125
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0125
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0125
systems (Huang et al., 1996; Miller and Woods, 1993; Mahboob
et al., 2001; Reus et al., 2003; Chen et al., 2005), including
conductance, mesenteric resistance and coronary arteries (Wiggers et al., 2008; Pecanha et al., 2010; Furieri et al., 2011).
Accordingly,superoxideanionproductionwas increasedinbasilar
arteriesfrommercurytreatedrats.Oneofthemainvascularsource
of mercury-induced oxidative stress generation is NADPHoxidase
(Wiggers et al., 2008; Pecanha et al., 2010; Furieri et al., 2011;
Lemosetal.,2012;Rizzettietal.,2013;Aguadoetal.,2013).Thefact
that vasoconstrictor response to 5-HT was reduced not only by
tiron but also byapocynin, points to NADPH oxidase as one of the
sources for the increased superoxide production. In addition, the
improvementofBK-inducedrelaxationproducedbytironandSOD
observedinarteriesfrommercury-treatedanimalsreinforcessuch
possibility. Another possible explanation for the occurrence of
oxidative stress in basilar arteries after mercury exposure is a
decrease in antioxidant defenses, similar to that occurs in other
tissues (Carvalho et al., 2008; Glaser et al., 2010; Martinez et al.,
2014). However, cerebrovascular protein expression of the three
SOD isoforms remains unaffected by mercury treatment. These
resultsareinagreementwiththoseobtainedinmesentericarteries
but in contrast to what occurs in aorta and coronary arteries
(Wiggersetal.,2008;Furierietal.,2011),confirmingthatmercury
effects depend on the vascular bed.
Increased vasoconstrictor prostanoids production might also
contribute to the NO bioavailability reduction and the subsequent
endothelialdysfunctionobservedincardiovasculardiseases(Feletou
et al., 2011; Hernanz et al., 2014). Herein we found that the COX
inhibitor indomethacin reduces 5-HT reactivity and increases BK-
inducedrelaxationonlyinbasilararteriesfrommercurytreatedrats,
suggesting the participation of COX-derived vasoconstrictor products in the reduced NO bioavailability. These findings are in
accordance to previous ones obtained in other vascular beds from
mercury treated rats (Pecanhaetal., 2010; Rizzetti etal., 2013).
In conclusion results presented here show, for the first time,
that basilar arteries are affected by chronic mercury exposure.
Thus, the vascular reactivity to 5HT was increased whereas the
endothelium dependent vasodilatorresponse toBK vas decreased
by mechanisms involving NO bioavailability reduction. We
proposethatincreasedROSproduction,likelyfromNADPHoxidase,
and COX-derived prostanoids contribute to the NO bioavailability
reduction. These findings offer further evidence that chronic
mercury exposure, even at small concentration, is hazardous and
might be an environmental risk factor for cerebral vasospasm
development.
Conflict of interest
The authors declare that there are no conflicts of interest.
Acknowledgements
This work was supported by Coordenação de Aperfeiçoamento
de Pessoal de Nível Superior—CAPES; Conselho Nacional de
Desenvolvimento Científico e Tecnológico—CNPq; Fundação de
Amparo a Pesquisa do Espírito Santo; Fundo Estadual de Ciência e
Tecnologia(39767531/07);MinisteriodeCienciaeInnovación(SAF
2012-36400),MinisteriodeEducación,CulturayDeporte(PHBP14-
00001);Pró-reitoria de Pesquisa—Universidade Federal do Pampa
(No10.031.12);InstitutodeSaludCarlosIII—ISCIII(RICRD12/0042/
0024).
Giulia A. Wiggers and Lorena Barros Furieri contributed to the
planning of the study design, carried out the study, analyzed the
data and prepared the manuscript. Dalton Valentim Vassallo,
Mercedes Salaices, Marisol Avendaño, Ana Maria Briones, Franck
Maciel Peçanha and María Jesús Alonso contributed to the
planning of the study design, analyzed the data and revised the
final version of the manuscript. All authors approved the final
version of the manuscript.
References
Aguado,A.,Galan,M.,Zhenyukh,O.,Wiggers,G.A.,Roque,F.R.,Redondo,S.,Pecanha,
F., Martin, A.,Fortuño, A.,Cachofeiro,V.,Tejerina, T., Salaices, M., Briones, A.M.,
2013. Mercury induces proliferation and reduces cell size in vascular smooth
muscle cells through MAPK, oxidative stress and cyclooxygenase-2 pathways.
Toxicol. Appl. Pharmacol. 268, 188–200.
Bjorkman,L.,Sandborgh-Englund,G.,Ekstrand,J.,1997. Mercuryinsalivaandfeces
after removal of amalgam fillings. Toxicol. Appl. Pharmacol.144, 156–162.
Bridges,C.C.,Zalups,R.K.,2010.Transportofinorganicmercuryandmethylmercury
in targettissues and organs. J. Toxicol. Environ. Health B Crit. Rev.13, 385–410.
Carmignani, M., Boscolo, P., 1984. Cardiovascular homeostasis in rats chronically
exposed to mercuric chloride. Arch. Toxicol. Suppl. 7, 383–388.
Carmignani, M., Boscolo, P., Artese, L., Del, R.G., Porcelli, G., Felaco, M., Volpe, A.R.,
Giuliano, G.,1992. Renal mechanisms in the cardiovascular effects of chronic
exposure to inorganic mercury in rats. Br. J. Ind. Med. 49, 226–232.
Carr, K.R., Zuckerman, S.L., Mocco, J., 2013. Inflammation, cerebral vasospasm, and
evolving theories of delayed cerebral ischemia. Neurol. Res. Int. 2013, 506584.
Carvalho,C.M.,Chew,E.H.,Hashemy,S.I.,Lu,J.,Holmgren,A.,2008.Inhibitionofthe
humanthioredoxinsystem:amolecularmechanismofmercurytoxicity.J.Biol.
Chem. 283,11913–11923.
Chen,C.,Qu,L.,Li,B.,Xing,L.,Jia,G.,Wang,T.,Gao,Y., Zhang,P., Li,M.,Chen,W.,Chai,
Z.,2005.IncreasedoxidativeDNAdamageasassessedbyurinary8-hydroxy-20-
deoxyguanosineconcentrations,andserumredoxstatusinpersonsexposedto
mercury. Clin. Chem. 51, 759–767.
Choi, B., Yeum, K.J., Park, S.J., Kim, K.N., Joo, N.S., 2015. Elevated serum ferritin and
mercury concentrations are associated with hypertension; analysis of the
fourth and fifth Korea national health and nutrition examination survey
(KNHANES IV-2 3, 2008-2009 and V-1, 2010). Environ. Toxicol. 30,101–108.
Ducruet, A.F., Gigante, P.R., Hickman, Z.L., Zacharia, B.E., Arias, E.J., Grobelny, B.T.,
Gorski,J.W.,Mayer,S.A.,ConnollyJr.,E.S.,2010.Geneticdeterminantsofcerebral
vasospasm, delayed cerebral ischemia, and outcome after aneurysmal
subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 30, 676–688.
Farina, M., Avila, D.S., da Rocha, J.B., Aschner, M., 2013. Metals, oxidative stressand
neurodegeneration: a focus on iron manganese and mercury. Neurochem. Int.
62, 575–594.
Feletou, M., Huang, Y., Vanhoutte,P.M., 2010. Vasoconstrictorprostanoids.Pflugers
Arch. 459, 941–950.
Feletou, M., Huang, Y., Vanhoutte, P.M., 2011. Endothelium-mediated control of
vascular tone: COX-1 and COX-2 products. Br. J. Pharmacol.164, 894–912.
Franco, J.L., Braga, H.C., Nunes, A.K., Ribas, C.M., Stringari, J., Silva, A.P., Garcia
Pomblum, S.C., Moro,A.M., Bohrer, D., Santos,A.R.,Dafre,A.L., Farina, M., 2007.
Lactational exposure to inorganic mercury: evidence of neurotoxic effects.
Neurotoxicol. Teratol. 29, 360–367.
Furieri,L.B., Galan, M.,Avendano,M.S., Garcia-Redondo, A.B.,Aguado, A.,Martinez,
S.,Cachofeiro,V.,Bartolome,M.V.,Alonso,M.J.,Vassallo,D.V.,Salaices,M.,2011.
Endothelial dysfunction of rat coronary arteries after exposure to low
concentrations of mercury is dependent on reactive oxygen species. Br. J.
Pharmacol.162,1819–1831.
Glaser,V.,Nazari,E.M.,Muller,Y.M.,Feksa,L.,Wannmacher,C.M.,Rocha,J.B.,deBem,
A.F., Farina, M., Latini, A.,2010. Effects of inorganic selenium administration in
methylmercury-induced neurotoxicity in mouse cerebral cortex. Int. J. Dev.
Neurosci. 28, 631–637.
Hernanz,R.,Briones,A.M.,Martín,A.,Beltrán,A.E.,Tejerina,T., Salaices,M.,Alonso,
M.J., 2008. Ouabain treatment increases nitric oxide bioavailability and
decreasessuperoxideanionproductionincerebralvessels.J.Hypertens.26(10),
1944–1954.
Hernanz, R., Briones, A.M., Salaices, M., Alonso, M.J., 2014. New roles for old
pathways?Acircuitousrelationshipbetweenreactiveoxygenspeciesandcyclooxygenase in hypertension. Clin. Sci. (Lond.) 126,111–121.
Houston, M.C., 2011. Role of mercury toxicity in hypertension, cardiovascular
disease, and stroke. J. Clin. Hypertens.13, 621–627.
Huang,Y.L.,Cheng,S.L.,Lin,T.H.,1996.Lipidperoxidationinratsadministratedwith
mercuric chloride. Biol. Trace Elem. Res. 52, 193–206.
Izzy,S.,Muehlschlegel,S.,2014.Cerebralvasospasmafteraneurysmalsubarachnoid
hemorrhage and traumatic brain injury. Curr. Treat. Options. Neurol.16, 278.
Kim,Y.N.,Kim,Y.A., Yang,A.R.,Lee,B.H.,2014.Relationshipbetweenbloodmercury
levelandriskofcardiovasculardiseases:resultsfromtheFourthKoreaNational
HealthandNutritionExaminationSurvey(KNHANESIV)2008–2009.Prev.Nutr.
Food Sci.19, 333–342.
Langworth, S., Sallsten, G., Barregard, L., Cynkier, I., Lind, M.L., Soderman, E.,1997.
Exposure to mercury vapor and impact on health in the dental profession in
Sweden. J. Dent. Res. 76, 1397–1404.
Lemos, N.B., Angeli, J.K., Faria, T.O., Ribeiro Junior, R.F., Vassallo, D.V., Padilha, A.S.,
Stefanon, I., 2012. Low mercury concentration produces vasoconstriction,
decreases nitric oxide bioavailability and increases oxidative stress in rat
conductance artery. PLoS One 7, e49005.
Mahboob, M., Shireen, K.F., Atkinson, A., Khan, A.T., 2001. Lipid peroxidation and
antioxidantenzymeactivityindifferentorgansofmiceexposedtolowlevelof
mercury. J. Environ. Sci. Health B. 36, 687–697.
288 G.A. Wiggers et al./NeuroToxicology 53 (2016) 282–289
(DEMO PDF Extractor SDK 8.0.0.2542-964319457)
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0130
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0130
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0130
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0130
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0130
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0135
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0135
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0135
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0135
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0140
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0140
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0140
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0145
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0145
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0145
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0150
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0150
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0155
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0155
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0155
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0155
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0160
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0160
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0160
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0160
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0160
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0165
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0165
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0165
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0170
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0170
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0170
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0175
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0175
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0180
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0180
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0180
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0180
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0185
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0185
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0190
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0190
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0190
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0190
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0195
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0195
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0195
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0200
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0200
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0200
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0205
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0205
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0205
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0205
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0210
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0210
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0210
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0210
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0210
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0215
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0215
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0215
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0215
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0220
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0220
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0225
[Link]
http://refhub.elsevier.com/S0161-813X(16)30020-1/sbref0225
Martinez, C.S., Torres, J.G., Pecanha, F.M., Anselmo-Franci, J.A., Vassallo, D.V.,
Salaices, M., Alonso, M.J., Wiggers, G.A., 2014. 60-Day chronic exposure to low
concentrations of HgCl
2
impairs sperm quality: hormonal imbalance and
oxidative stress as potential routes for reproductive dysfunction in rats. PLoS
One 9, e111202.
Mello-Carpes, P.B., Barros, W., Borges, S., Alves, N., Rizzetti, D., Peçanha, F.M.,
Vassallo, D.V., Wiggers, G.A., Izquierdo, I., 2013. Chronic exposure to low
mercury chloride concentration induces object recognition and aversive
memories deficits in rats. Int. J. Dev. Neurosci. 31 (Nov (7)), 468–472.
McKelvey,W., Gwynn,R.C.,Jeffery,N.,Kass,D.,Thorpe,L.E.,Garg,R.K.,Palmer,C.D.,
Parsons,P.J.,2007.Abiomonitoringstudyofleadcadmium,andmercuryinthe
blood of New York city adults. Environ. Health Perspect.115, 1435–1441.
Miller, D.M., Woods, J.S.,1993. Urinary porphyrins as biological indicators of
oxidative stress in the kidney. Interaction of mercury and cephaloridine.
Biochem. Pharmacol. 46, 2235–2241.
National Academy of Sciences, 2000. Toxicological Effects of Methylmercury.
National Research Council, Washington, DC, USA.
Nyland,J.F.,Fairweather,D.,Shirley,D.L.,Davis,S.E.,Rose,N.R.,Silbergeld,E.K.,2012.
Low-dose inorganic mercury increases severity and frequency of chronic
coxsackievirus-inducedautoimmunemyocarditisinmice.Toxicol.Sci.125,134–
143.
Pecanha, F.M., Wiggers, G.A., Briones, A.M., Perez-Giron, J.V., Miguel, M., Garcia-
Redondo, A.B., Vassallo, D.V., Alonso, M.J., Salaices, M., 2010. The role of
cyclooxygenase (COX)-2 derived prostanoids on vasoconstrictor responses to
phenylephrine is increased by exposure to low mercury concentration. J.
Physiol. Pharmacol. 61, 29–36.
Perottoni, J., Lobato, L.P., Silveira, A., Rocha, J.B., Emanuelli, T., 2004. Effects of
mercury and selenite on delta-aminolevulinate dehydratase activity and on
selected oxidative stress parameters in rats. Environ. Res. 95,166–173.
Reus,I.S.,Bando,I.,Andres,D.,Cascales,M.,2003.Relationshipbetweenexpression
of HSP70 and metallothionein and oxidative stress during mercury chloride
induced acute liver injury in rats. J. Biochem. Mol. Toxicol.17, 161–168.
Rice, D.C., 2004. The US EPA reference dose for methylmercury: sources of
uncertainty. Environ. Res. 95, 406–413.
Rizzetti, D.A., Torres, J.G., Escobar, A.G., Pecanha, F.M., Santos, F.W., Puntel, R.L.,
Alonso, M.J., Briones, A.M., Salaices, M., Vassallo, D.V., Wiggers, G.A., 2013.
Apocynin prevents vascular effects caused by chronic exposure to low
concentrations of mercury. PLoS One 8, e55806.
Salonen, J.T., Nyyssönen, K., Salonen, R.,1995. Fish intake and the risk of coronary
disease. N. Engl. J. Med. 333 (14), 937.
Salonen, J.T., Seppanen, K., Lakka, T.A., Salonen, R., Kaplan, G.A., 2000. Mercury
accumulation and accelerated progression of carotid atherosclerosis: a
population-based prospective 4-year follow-up study in men in eastern
Finland. Atherosclerosis 148, 265–273.
Shirkhanloo, H., Mehrjerdi, M.A., Hassani, H., 2014. Identify occupational and nonoccupational health to mercury exposure in dental personnel. Arch. Environ.
Occup. Health doi:http://dx.doi.org/10.1080/19338244.2014.964391.
Stern, A.H., 2005. A revised probabilistic estimate of the maternal methyl mercury
intake dose corresponding to a measured cord blood mercury concentration.
Environ. Health Perspect.113, 155–163.
Tinkov, A.A., Ajsuvakova, O.P., Skalnaya, M.G., Popova, E.V., Sinitskii, A.I.,
Nemereshina,O.N.,Gatiatulina,E.R.,Nikonorov,A.A.,Skalny,A.V.,2015.Mercury
and metabolic syndrome: a review of experimental and clinical observations.
Biometals 28 (2), 231–254.
Virtanen,J.K.,Voutilainen,S.,Rissanen,T.H.,Mursu,J.,Tuomainen,T.P.,Korhonen,M.
J.,Valkonen,V.P.,Seppanen,K.,Laukkanen,J.A.,Salonen,J.T.,2005.Mercury,fish
oils,andriskofacutecoronaryeventsandcardiovasculardiseasecoronaryheart
disease,andall-causemortalityinmenineasternFinland.Arterioscler.Thromb.
Vasc. Biol. 25, 228–233.
Wiggers,G.A.,Pecanha,F.M., Briones,A.M.,Perez-Giron,J.V.,Miguel,M.,Vassallo,D.
V., Cachofeiro, V., Alonso, M.J., Salaices, M., 2008. Low mercuryconcentrations
cause oxidative stress and endothelial dysfunction in conductance and
resistance arteries. Am. J. Physiol Heart Circ. Physiol. 295, H1033–H1043.
Wolf, M.B., Baynes, J.W., 2007. Cadmium and mercury cause an oxidative stressinduced endothelial dysfunction. Biometals 20, 73–81.
Zhang,Y., Chen,X.,Yang,Y., Wang,D.,Liu,X.,2011.Effectofdissolvedorganicmatter
on mercury release from water body. J. Environ. Sci. (China) 23, 912–917.
G.A. Wiggers et al./NeuroToxicology 53 (2016) 282–289 289
(TRIAL PDF Extractor SDK 8.0.0.2542-1189112807)
